Myocardial Contraction

People with excess adiposity in young adulthood were more likely to have adverse cardiac structure and function later in life compared with people without it, researchers reported in the European Heart Journal.

Impulse Dynamics announced it received FDA and CE Mark approval and launched its miniature next-generation cardiac contractility modulation therapy delivery system.

In the phase 2 SEISMiC trial, istaroxime met its primary endpoint of improving systolic BP profile at 6 hours in patients with cardiogenic shock, according to the topline results announced by Windtree Therapeutics.